Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN16995641
ISRCTN16995641
Completed
Not Applicable

The effects of botulinum toxin A on patients with idiopathic detrusor overactivity. A double-blind, randomised, placebo-controlled trial.

Guy's and St Thomas' NHS Foundation Trust (UK)0 sites32 target enrollmentOctober 19, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsOveractive bladder symptoms and idiopathic detrusor overactivity.Urological and Genital DiseasesOther disorders of bladder

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Overactive bladder symptoms and idiopathic detrusor overactivity.
Sponsor
Guy's and St Thomas' NHS Foundation Trust (UK)
Enrollment
32
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 19, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Guy's and St Thomas' NHS Foundation Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • •1\. Refractory to traditional anticholinergic therapy either due to poor efficacy or side effects
  • •2\. Proven detrusor overactivity on urodynamic studies
  • •3\. Detrusor overactivity of non\-neurogenic origin

Exclusion Criteria

  • •1\. Pregnancy or planned pregnancy
  • •2\. Breast Feeding
  • •3\. Indwelling catheter
  • •4\. Current anticoagulation e.g. heparin or warfarin
  • •5\. Neurogenic detrusor overactivity
  • •6\. Painful bladder syndromes
  • •7\. Previous bladder surgery e.g. augmentation cystoplasty

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
The effect of botox in treatment of scarKeloid Lesion.Diseases of skin and soft tissue
IRCT2016020926489N1School of Medicine, Tehran University of Medical Sciences86
Active, not recruiting
Not Applicable
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with a stiff knee gait. - Botulinum toxin type A injections in stiff knee gaitStroke patients with stiff knee gait. Stiff knee gait is characterized as a diminished knee flexion during swing phase of gait. It is common in stroke patients.
EUCTR2009-018226-29-NL26
Completed
Phase 3
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with stiff knee gaitstiff knee gaitstiff-legged knee1000796310057166
NL-OMON39359Revalidatiecentrum Het Roessingh26
Completed
Phase 2
Assessment of the botulinum toxin type A effect on Intensified Raynauds Phenomenon in Sclerodermic patientsSystemic sclerosis [scleroderma].Systemic sclerosis [scleroderma]
IRCT20200106046023N1Oroumia University of Medical Sciences11
Completed
Not Applicable
comparison of the effect of botulinium toxin A injection with placebo in reducing the pain of patients with myofacial paitemporomandibular disorder.Temporomandibular joint disorders
IRCT2016051527894N2Vice chancellor for research of Ahvaz Jundishapur University of Medical Sciences34